EDVA Company Profile and Key Details

Average 10-day trading volume of 9.13 million shares is significantly above the 3-month average of 4.40 million, indicating heightened recent market interest.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Endovia Health Sciences, Inc. (AMEX:EDVA) closed at $0.19 USD, losing -$0.02 (-7.56%) from the previous close of $0.21. The stock is currently mid-range between its 52-week high and low $0.17 and $13.40. With a market capitalization of about $1.22 million, Endovia Health Sciences, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-1.09). Key stats such as the average daily volume over the past year has been around 6.17 million shares, volume is running light vs its 52-week average. Headquartered in Fort Lauderdale, FL, Endovia Health Sciences, Inc. operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO Brady Cobb, the company employs approximately 2 people and listed since August 24, 2026. Endovia Health Sciences is a diversified cannabinoid-based health sciences platform.

Our AI price prediction model suggests that Endovia Health Sciences, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -10.34%, with price expected at $0.17 by October 07, 2026, within a range of $0.16 to $0.19 3-Month Outlook: Projected fall of -100.0%, reaching $0.00 by December 22, 2026, with a range of $0.00 to $0.33. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by September 23, 2027, within a range of $0.00 to $0.00.

Our AI forecast model points to short-term weakness (-10.34% over two weeks), a medium-term fall (-100.0% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.